Hereditary Neuropathy Foundation BlogStay up to date with our most recent news and updates on CMT and INs.
Hope on the Horizon: CMT & FDA Patient-Focused Drug Development Meeting for Charcot-Marie-Tooth to be Held in 2018
HNF will be holding a landmark externally-led Patient-Focused Drug Development (PFDD) Meeting CMT & INs in Washington, D.C. on September 28, 2018. The meeting will be held in conjunction with September National CMT Awareness Month.read more
Pharnext completed patient enrollment for the international Phase 3 clinical trial of PXT3003, Pharnext’s lead PLEODRUG ©, for treatment of CMT1A.read more
HNPP is the second most common form of CMT/IN and may affect approximately 15,000 in the USA. Help us find a cure today!read more
HNF is proud to announce that our annual CMT Summit will include the HNPP community Friday, November 3, 2017, in Cambridge, Massachusetts.read more
Amanda Pool shares her experience with the online Inspire CMT Community.read more
Learn how this CMT1A patient uses the AlterG treadmill to manage her CMT symptoms.read more